Pittenger & Anderson’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$622K Buy
+5,685
New +$634K 0.02% 194

Other funds holding PPH

Pittenger & Anderson's PPH Position: Q3 2026 in Review

Pittenger & Anderson opened a new position in VanEck Pharmaceutical ETF (PPH) in Q3 2026: 5,685 shares worth $622K. The stake represents 0.02% of the portfolio and ranks #194 among its holdings.

156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Pittenger & Anderson held 5,685 shares of VanEck Pharmaceutical ETF worth $622K as of Q3 2026.
  • VanEck Pharmaceutical ETF was a new Pittenger & Anderson position in Q3 2026.
  • VanEck Pharmaceutical ETF made up 0.02% of Pittenger & Anderson's portfolio in Q3 2026, its #194 holding.
  • 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.